Metraipolis › archive › dc_df65dd706ed9

Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia — Europe PMC PMID:41445506

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41445506
DOI
10.3724/abbs.2025135
License (as archived)
solo-consultazione
Archived
2026-11-10T18:08:33.084Z
SHA-256 of the archived text
5c8656bf15ca7b74c402a6c7d23b74f76a7e136e46f7ef88445734c9f73fe3f5
Stable URL of this page
https://metraipolis.com/documento/dc_df65dd706ed9

How to cite

Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia — Europe PMC PMID:41445506 — Europe PMC (en), https://europepmc.org/article/MED/41445506 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df65dd706ed9 (Metraipolis archive dc_df65dd706ed9, sha256 5c8656bf15ca7b74c402a6c7d23b74f76a7e136e46f7ef88445734c9f73fe3f5)
BibTeX
@misc{dcdf65dd706ed9,
  title = {Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia — Europe PMC PMID:41445506},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41445506},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df65dd706ed9; sha256 5c8656bf15ca7b74c402a6c7d23b74f76a7e136e46f7ef88445734c9f73fe3f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41445506. Agents can read the archived copy with the MCP tool read_document.